S. Roever

461 total citations
6 papers, 324 citations indexed

About

S. Roever is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, S. Roever has authored 6 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 1 paper in Organic Chemistry. Recurrent topics in S. Roever's work include Neuropeptides and Animal Physiology (3 papers), Receptor Mechanisms and Signaling (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). S. Roever is often cited by papers focused on Neuropeptides and Animal Physiology (3 papers), Receptor Mechanisms and Signaling (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). S. Roever collaborates with scholars based in Switzerland. S. Roever's co-authors include Andrea M. Cesura, Juergen Wichmann, Geo Adam, Frank M. Dautzenberg, François Jenck, Kenneth Lundström, James R. Martin, Jean‐Luc Moreau, Gavin J. Kilpatrick and Sabine Kolczewski and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Pharmacology and Experimental Therapeutics and ChemInform.

In The Last Decade

S. Roever

6 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Roever Switzerland 4 275 239 81 47 32 6 324
Hiroo Kuroda Japan 8 270 1.0× 131 0.5× 64 0.8× 54 1.1× 52 1.6× 16 391
J. Wichmann Switzerland 9 337 1.2× 271 1.1× 68 0.8× 19 0.4× 16 0.5× 9 363
Smriti Iyengar United States 9 294 1.1× 226 0.9× 72 0.9× 80 1.7× 30 0.9× 9 420
Barton G. Weick United States 11 322 1.2× 153 0.6× 49 0.6× 41 0.9× 29 0.9× 16 470
Juergen Wichmann Switzerland 10 514 1.9× 434 1.8× 199 2.5× 57 1.2× 23 0.7× 12 572
I. Bougault France 10 256 0.9× 245 1.0× 40 0.5× 34 0.7× 9 0.3× 10 355
Sylvia Montañez United States 10 288 1.0× 154 0.6× 29 0.4× 33 0.7× 31 1.0× 14 404
Linda Rorick‐Kehn United States 7 227 0.8× 208 0.9× 64 0.8× 46 1.0× 19 0.6× 8 368
Carolina Birgner Sweden 10 281 1.0× 199 0.8× 30 0.4× 28 0.6× 8 0.3× 12 419
W.C. Graham United Kingdom 8 450 1.6× 161 0.7× 33 0.4× 13 0.3× 15 0.5× 9 538

Countries citing papers authored by S. Roever

Since Specialization
Citations

This map shows the geographic impact of S. Roever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Roever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Roever more than expected).

Fields of papers citing papers by S. Roever

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Roever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Roever. The network helps show where S. Roever may publish in the future.

Co-authorship network of co-authors of S. Roever

This figure shows the co-authorship network connecting the top 25 collaborators of S. Roever. A scholar is included among the top collaborators of S. Roever based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Roever. S. Roever is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Gill, R., Alexander Alanine, Anne Bourson, et al.. (2002). Pharmacological Characterization of Ro 63-1908 (1-[2-(4-Hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a Novel Subtype-Selective N-Methyl-d-Aspartate Antagonist. Journal of Pharmacology and Experimental Therapeutics. 302(3). 940–948. 45 indexed citations
2.
3.
Roever, S., Geo Adam, Andrea M. Cesura, et al.. (2000). ChemInform Abstract: High‐Affinity, Nonpeptide Agonists for the ORL1 (Orphanin FQ/Nociceptin) Receptor.. ChemInform. 31(28). 9 indexed citations
4.
Jenck, François, Juergen Wichmann, Frank M. Dautzenberg, et al.. (2000). A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: Anxiolytic profile in the rat. Proceedings of the National Academy of Sciences. 97(9). 4938–4943. 235 indexed citations
5.
6.
Jakob‐Roetne, Roland, et al.. (1996). ChemInform Abstract: Design and Synthesis of Novel and Potent Monoamine Oxidase Inhibitors.. ChemInform. 27(10). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroo Kuroda Breakdown of academic impact, for papers by J. Wichmann Breakdown of academic impact, for papers by Smriti Iyengar Breakdown of academic impact, for papers by Barton G. Weick Breakdown of academic impact, for papers by Juergen Wichmann Breakdown of academic impact, for papers by I. Bougault Breakdown of academic impact, for papers by Sylvia Montañez Breakdown of academic impact, for papers by Linda Rorick‐Kehn Breakdown of academic impact, for papers by Carolina Birgner Breakdown of academic impact, for papers by W.C. Graham
Rankless by CCL
2026